Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-25-074440
Filing Date
2025-08-06
Accepted
2025-08-06 06:03:05
Documents
15
Effectiveness Date
2025-08-06

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2522417d1_s8.htm S-8 54672
2 EXHIBIT 5.1 tm2522417d1_ex5-1.htm EX-5.1 11907
3 EXHIBIT 23.1 tm2522417d1_ex23-1.htm EX-23.1 2245
4 EX-FILING FEES tm2522417d1_ex-filingfees.htm   iXBRL EX-FILING FEES 20522
5 GRAPHIC tm2522417d1_ex5-1img01.jpg GRAPHIC 2659
  Complete submission text file 0001104659-25-074440.txt   221329

Data Files

Seq Description Document Type Size
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2522417d1_ex-filingfees_htm.xml XML 7453
Mailing Address 611 GATEWAY BOULEVARD, SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 900 SOUTH SAN FRANCISCO CA 94080 650-624-1100
RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)

EIN.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)